London Plane Tree (Pla a 2) IgE Test · Blood

If your seasonal allergies flare up when London plane trees release pollen, you want to know whether your immune system is actually reacting to that pollen or to something else in the air. This blood test measures Pla a 2 specific IgE, an antibody (a Y-shaped immune protein) directed at one particular molecule from London plane tree pollen.

Knowing your Pla a 2 IgE level helps clarify whether plane tree is a real driver of your respiratory allergy and helps your allergist decide whether allergen-specific treatment makes sense. It is a precision tool layered on top of standard skin or extract testing, not a replacement for them.

What Pla a 2 Actually Is

Pla a 2 (the second major allergen identified from Platanus acerifolia, the London plane tree) is a protein called a polygalacturonase. Your immune system can recognize this protein and produce IgE (immunoglobulin E) antibodies against it. Those antibodies sit on mast cells (immune cells that release histamine) and basophils (a type of white blood cell), and when you breathe in plane tree pollen, they trigger the sneezing, congestion, itchy eyes, and sometimes wheezing of an allergic reaction.

Unlike older tests that use a whole pollen extract (a soup of many proteins from the pollen), this assay measures your antibody response to a single, well-defined component. That makes the result more precise. Pla a 2 is considered mainly species-specific to plane tree, so a positive result points to genuine plane tree sensitization rather than cross-reactivity with other pollens.

Why Plane Tree Pollen Matters

London plane trees line streets across cities in Europe, Australia, Asia, and parts of the Americas. In one Sydney study, Platanus pollen made up a large share of all pollen counted over a season, and about a quarter of people with seasonal symptoms in that area showed skin test sensitization to it. In the largest molecular study of plane tree allergic patients, 54.1% had IgE to Pla a 2, putting it squarely among the major sensitizing components of this pollen.

That same study found that Pla a 2 reactivity tracked with respiratory symptoms (rhinitis and asthma) and was inversely related to systemic food reactions. In plain terms: people whose immune system targets Pla a 2 are more likely to have hay fever and breathing symptoms when plane tree pollen is in the air, and less likely to have severe food reactions tied to plane tree sensitization.

What a Positive Result Suggests

A measurable Pla a 2 IgE level means your immune system has produced antibodies that specifically recognize this plane tree protein. Across inhalant allergens in general, higher specific IgE levels track with a higher chance of allergic symptoms on exposure and, in larger studies, with more persistent rhinitis and asthma over time. The relationship is dose-dependent, meaning higher antibody levels typically correlate with stronger reactions, though the exact symptom threshold for Pla a 2 alone has not been mapped in research.

A positive Pla a 2 result is most informative when paired with your symptom history. Sensitization without symptoms is possible, so the lab number is one piece of the picture. The clinical meaning crystallizes when the result lines up with a pattern of springtime nasal, eye, or chest symptoms during plane tree pollination.

What a Negative Result Means

A negative or very low Pla a 2 IgE result argues against London plane tree being a meaningful driver of your symptoms. In population data, the absence of inhalant-specific IgE is associated with much lower rates of allergic rhinitis, conjunctivitis, and asthma. If your seasonal symptoms persist despite a negative Pla a 2, attention should shift to other pollens, dust mites, mold, or non-allergic triggers.

Respiratory Allergy and Asthma

Tree pollen sensitization, including the Pla a component cluster, is part of the broader pattern tied to allergic rhinitis and asthma. A study of 6,391 adults across multiple countries found that the risk of combined nasal and asthma-like symptoms rises steadily as specific IgE to common inhalant allergens climbs. People with persistent rhinitis and asthma carry higher allergen sensitization and type 2 inflammation markers than those whose symptoms remit.

In children, broader pollen sensitization is associated with more severe nasal symptoms and lower quality of life. While these findings come from studies measuring multiple allergens rather than Pla a 2 in isolation, they place Pla a 2 IgE within the well-established framework linking specific IgE to allergic airway disease.

Food Allergy Connections

London plane tree allergy can sometimes accompany pollen food allergy syndrome (itchy mouth or throat after eating certain raw fruits or nuts), but that link runs primarily through a different plane tree component called Pla a 3, not Pla a 2. In a study of 939 plane tree allergic patients, those with Pla a 3 antibodies had both local and systemic food-induced reactions, while Pla a 2 reactivity was associated with respiratory symptoms and fewer systemic food reactions.

Patients co-sensitized to both Pla a 2 and Pla a 3 had a lower past incidence of severe food-induced reactions than those sensitized to Pla a 3 alone. This is a useful pattern: testing Pla a 2 alongside Pla a 3 helps separate respiratory-only plane tree allergy from the food-allergic subset.

How This Test Compares to Skin Tests and Whole-Extract IgE

A traditional skin prick test or a whole-extract blood IgE for plane tree pollen measures your reaction to a mixture of proteins. That can pick up cross-reactivity from unrelated pollens (a panallergen called profilin is a common culprit), making it harder to know whether plane tree itself is the problem. Pla a 2 IgE narrows the question to one specific, species-typical protein.

In a study of plane tree allergic patients, a combined Pla a 1 plus Pla a 2 component test captured most of the IgE-binding capacity of the whole extract. Sensitivity was high in patients allergic only to plane tree and remained strong in patients allergic to multiple pollens, with no false positives reported in controls. That makes the component test a sharper instrument when polysensitization is muddying the picture.

How It Changes Treatment Decisions

The most concrete clinical payoff of component testing shows up in allergen immunotherapy decisions. The INMUNOCAT study followed pollen-polysensitized patients in Catalonia and found that adding a molecular panel including Pla a 1, 2, and 3 to standard work-up changed immunotherapy prescriptions in roughly half of cases. Use of allergen-specific immunotherapy rose substantially once clinicians knew which components their patients were actually reacting to.

For you, that translates into a real decision point. If Pla a 2 is the protein driving your symptoms, immunotherapy targeted at plane tree becomes a defensible long-term option. If you are sensitized to a different pollen entirely, dragging out plane tree treatment for years is a waste.

Why One Reading Is Not Enough

Specific IgE levels can shift over time as your exposures change, your immune system matures or ages, and any treatment you start kicks in. A single reading captures a moment. The more informative question is the trajectory: is your Pla a 2 IgE rising, stable, or falling? That arc tells you whether sensitization is intensifying or whether interventions are taking hold.

Get a baseline before pollen season if possible, since acute high-dose exposure can transiently shift levels. If you start an intervention like allergen immunotherapy, retest in 6 to 12 months to see how your antibody profile is responding. Otherwise, an annual recheck during the same seasonal window keeps your data comparable year to year. Trending Pla a 2 alongside related components (Pla a 1 and Pla a 3) gives the fullest picture of how your plane tree sensitization is evolving.

What to Do If Your Result Is Positive

A positive Pla a 2 IgE that matches a clear symptom pattern during plane tree pollination season should push you toward a structured allergy work-up rather than indefinite over-the-counter management. The natural next step is a broader component panel including Pla a 1, Pla a 3, and other relevant tree and grass pollen components, ideally interpreted by an allergist.

Pairing your Pla a 2 result with skin prick testing and extract IgE rounds out the picture. If you have any history of itchy mouth, swelling, or systemic reactions after raw fruits or nuts, add Pla a 3 and other non-specific lipid transfer protein (a class of plant allergens often abbreviated nsLTP) components to clarify your food allergy risk. If you have asthma or persistent rhinitis despite medications, that combination of findings makes a stronger case for considering allergen immunotherapy.

When Results Can Be Misleading

Specific IgE testing is generally reliable, but a few situations can muddy interpretation:

• Recent allergen exposure: Heavy pollen exposure in the days before a draw can transiently raise specific IgE, while testing far out of season may show lower levels than your peak.
• Polysensitization without true plane tree allergy: If you have antibodies to a panallergen like profilin, broader plane tree extract tests may light up even when Pla a 2 itself is negative. The component test sorts this out.
• Asymptomatic sensitization: A positive Pla a 2 in someone with no symptoms during plane tree pollination is not a diagnosis of disease, just evidence of an immune response. Clinical context decides what to do with it.
• Recent immunotherapy or biologic therapy: Treatments that alter IgE-driven biology can shift specific IgE levels over months. Time your testing thoughtfully if you are on such therapies.

How This Fits the Bigger Allergy Picture

Pla a 2 IgE is one tile in a mosaic. Most allergic patients are sensitized to multiple pollens, and the clinical art is figuring out which ones are doing the real damage. Component testing turns a fuzzy whole-extract result into a sharp molecular map. For someone whose spring symptoms align with plane tree pollination, knowing your Pla a 2 status is the difference between guessing and targeting.